Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia

Relapse after chemotherapy is inevitable in the majority of patients with acute myeloid leukemia (AML). Thus, it is necessary to develop novel therapies that have different antileukemic mechanisms. Recent advances in immunology and identification of promising leukemia-associated antigens open the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Norimitsu, Kitawaki, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199067/
https://www.ncbi.nlm.nih.gov/pubmed/22028726
http://dx.doi.org/10.1155/2011/104926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199067/
https://www.ncbi.nlm.nih.gov/pubmed/22028726
http://dx.doi.org/10.1155/2011/104926

Ejemplares similares